116 related articles for article (PubMed ID: 9875340)
1. Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain.
Martres MP; Demeneix B; Hanoun N; Hamon M; Giros B
Eur J Neurosci; 1998 Dec; 10(12):3607-16. PubMed ID: 9875340
[TBL] [Abstract][Full Text] [Related]
2. Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer.
Fabre V; Boutrel B; Hanoun N; Lanfumey L; Fattaccini CM; Demeneix B; Adrien J; Hamon M; Martres MP
J Neurosci; 2000 Jul; 20(13):5065-75. PubMed ID: 10864964
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
[TBL] [Abstract][Full Text] [Related]
4. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
[TBL] [Abstract][Full Text] [Related]
5. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
[TBL] [Abstract][Full Text] [Related]
6. In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions.
Hoffman AF; Gerhardt GA
J Neurochem; 1998 Jan; 70(1):179-89. PubMed ID: 9422361
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
[TBL] [Abstract][Full Text] [Related]
8. Decreased plasma membrane expression of striatal dopamine transporter in aging.
Salvatore MF; Apparsundaram S; Gerhardt GA
Neurobiol Aging; 2003 Dec; 24(8):1147-54. PubMed ID: 14643386
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
Hoffman AF; Lupica CR; Gerhardt GA
J Pharmacol Exp Ther; 1998 Nov; 287(2):487-96. PubMed ID: 9808671
[TBL] [Abstract][Full Text] [Related]
11. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
[TBL] [Abstract][Full Text] [Related]
12. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Van Kampen JM; McGeer EG; Stoessl AJ
Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
15. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
16. Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum.
Lonjon M; Quentien MH; Risso JJ; Michiels JF; Carre E; Rostain JC; Darbin O
Neurosci Lett; 2004 Jan; 354(2):131-4. PubMed ID: 14698456
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of the human dopamine transporter in a neuronal cell line.
Zhang L; Elmer LW; Little KY
Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282
[TBL] [Abstract][Full Text] [Related]
18. Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.
Barc S; Page G; Barrier L; Garreau L; Guilloteau D; Fauconneau B; Chalon S
J Neurochem; 2002 Feb; 80(3):365-74. PubMed ID: 11905985
[TBL] [Abstract][Full Text] [Related]
19. Peptide derived from insulin with regulatory activity of dopamine transporter.
Liu Z; Wang Y; Zhao W; Ding J; Mei Z; Guo L; Cui D; Fei J
Neuropharmacology; 2001 Sep; 41(4):464-71. PubMed ID: 11543766
[TBL] [Abstract][Full Text] [Related]
20. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
